Global Kidney Disease Drugs Sales Market Report 2021

1 Kidney Disease Drugs Market Overview

• 1.1 Kidney Disease Drugs Product Scope
• 1.2 Kidney Disease Drugs Segment by Type
  • 1.2.1 Global Kidney Disease Drugs Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Tablets
  • 1.2.3 Capsule
  • 1.2.4 Other
• 1.3 Kidney Disease Drugs Segment by Application
  • 1.3.1 Global Kidney Disease Drugs Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Chronic Glomerulonephritis
  • 1.3.3 Nephrotic Syndrome
  • 1.3.4 Chronic Renal Failure
  • 1.3.5 Kidney Stones
  • 1.3.6 Renal Cyst (polycystic Kidney)
  • 1.3.7 Diabetic Nephropathy
  • 1.3.8 Hypertensive Nephropathy
  • 1.3.9 Purpura Nephritis
  • 1.3.10 Lupus Nephritis
  • 1.3.11 Pediatric Kidney Disease
• 1.4 Kidney Disease Drugs Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Kidney Disease Drugs Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Kidney Disease Drugs Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Kidney Disease Drugs Price Trends (2016-2027)

2 Kidney Disease Drugs Estimates and Forecasts by Region

• 2.1 Global Kidney Disease Drugs Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Kidney Disease Drugs Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Kidney Disease Drugs Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Kidney Disease Drugs Revenue Market Share by Region (2016-2021)
• 2.3 Global Kidney Disease Drugs Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Kidney Disease Drugs Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Kidney Disease Drugs Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Kidney Disease Drugs Estimates and Projections (2016-2027)
  • 2.4.2 Europe Kidney Disease Drugs Estimates and Projections (2016-2027)
  • 2.4.3 China Kidney Disease Drugs Estimates and Projections (2016-2027)
  • 2.4.4 Japan Kidney Disease Drugs Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Kidney Disease Drugs Estimates and Projections (2016-2027)
  • 2.4.6 India Kidney Disease Drugs Estimates and Projections (2016-2027)

3 Global Kidney Disease Drugs Competition Landscape by Players

• 3.1 Global Top Kidney Disease Drugs Players by Sales (2016-2021)
• 3.2 Global Top Kidney Disease Drugs Players by Revenue (2016-2021)
• 3.3 Global Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Kidney Disease Drugs as of 2020)
• 3.4 Global Kidney Disease Drugs Average Price by Company (2016-2021)
• 3.5 Manufacturers Kidney Disease Drugs Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Kidney Disease Drugs Market Size by Type

• 4.1 Global Kidney Disease Drugs Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Kidney Disease Drugs Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Kidney Disease Drugs Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Kidney Disease Drugs Price by Type (2016-2021)
• 4.2 Global Kidney Disease Drugs Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Kidney Disease Drugs Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Kidney Disease Drugs Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Kidney Disease Drugs Price Forecast by Type (2022-2027)

5 Global Kidney Disease Drugs Market Size by Application

• 5.1 Global Kidney Disease Drugs Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Kidney Disease Drugs Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Kidney Disease Drugs Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Kidney Disease Drugs Price by Application (2016-2021)
• 5.2 Global Kidney Disease Drugs Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Kidney Disease Drugs Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Kidney Disease Drugs Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Kidney Disease Drugs Price Forecast by Application (2022-2027)

6 North America Kidney Disease Drugs Market Facts & Figures

• 6.1 North America Kidney Disease Drugs Sales by Company
  • 6.1.1 North America Kidney Disease Drugs Sales by Company (2016-2021)
  • 6.1.2 North America Kidney Disease Drugs Revenue by Company (2016-2021)
• 6.2 North America Kidney Disease Drugs Sales Breakdown by Type
  • 6.2.1 North America Kidney Disease Drugs Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Kidney Disease Drugs Sales Breakdown by Type (2022-2027)
• 6.3 North America Kidney Disease Drugs Sales Breakdown by Application
  • 6.3.1 North America Kidney Disease Drugs Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Kidney Disease Drugs Sales Breakdown by Application (2022-2027)

7 Europe Kidney Disease Drugs Market Facts & Figures

• 7.1 Europe Kidney Disease Drugs Sales by Company
  • 7.1.1 Europe Kidney Disease Drugs Sales by Company (2016-2021)
  • 7.1.2 Europe Kidney Disease Drugs Revenue by Company (2016-2021)
• 7.2 Europe Kidney Disease Drugs Sales Breakdown by Type
  • 7.2.1 Europe Kidney Disease Drugs Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Kidney Disease Drugs Sales Breakdown by Type (2022-2027)
• 7.3 Europe Kidney Disease Drugs Sales Breakdown by Application
  • 7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)

8 China Kidney Disease Drugs Market Facts & Figures

• 8.1 China Kidney Disease Drugs Sales by Company
  • 8.1.1 China Kidney Disease Drugs Sales by Company (2016-2021)
  • 8.1.2 China Kidney Disease Drugs Revenue by Company (2016-2021)
• 8.2 China Kidney Disease Drugs Sales Breakdown by Type
  • 8.2.1 China Kidney Disease Drugs Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Kidney Disease Drugs Sales Breakdown by Type (2022-2027)
• 8.3 China Kidney Disease Drugs Sales Breakdown by Application
  • 8.3.1 China 314 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 314 Sales Breakdown by Application (2022-2027)

9 Japan Kidney Disease Drugs Market Facts & Figures

• 9.1 Japan Kidney Disease Drugs Sales by Company
  • 9.1.1 Japan Kidney Disease Drugs Sales by Company (2016-2021)
  • 9.1.2 Japan Kidney Disease Drugs Revenue by Company (2016-2021)
• 9.2 Japan Kidney Disease Drugs Sales Breakdown by Type
  • 9.2.1 Japan Kidney Disease Drugs Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Kidney Disease Drugs Sales Breakdown by Type (2022-2027)
• 9.3 Japan Kidney Disease Drugs Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Kidney Disease Drugs Market Facts & Figures

• 10.1 Southeast Asia Kidney Disease Drugs Sales by Company
  • 10.1.1 Southeast Asia Kidney Disease Drugs Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Kidney Disease Drugs Revenue by Company (2016-2021)
• 10.2 Southeast Asia Kidney Disease Drugs Sales Breakdown by Type
  • 10.2.1 Southeast Asia Kidney Disease Drugs Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Kidney Disease Drugs Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Kidney Disease Drugs Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Kidney Disease Drugs Market Facts & Figures

• 11.1 India Kidney Disease Drugs Sales by Company
  • 11.1.1 India Kidney Disease Drugs Sales by Company (2016-2021)
  • 11.1.2 India Kidney Disease Drugs Revenue by Company (2016-2021)
• 11.2 India Kidney Disease Drugs Sales Breakdown by Type
  • 11.2.1 India Kidney Disease Drugs Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Kidney Disease Drugs Sales Breakdown by Type (2022-2027)
• 11.3 India Kidney Disease Drugs Sales Breakdown by Application
  • 11.3.1 India Kidney Disease Drugs Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Kidney Disease Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Kidney Disease Drugs Business

• 12.1 GlaxoSmithKline
  • 12.1.1 GlaxoSmithKline Corporation Information
  • 12.1.2 GlaxoSmithKline Business Overview
  • 12.1.3 GlaxoSmithKline Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 GlaxoSmithKline Kidney Disease Drugs Products Offered
  • 12.1.5 GlaxoSmithKline Recent Development
• 12.2 Sanofi
  • 12.2.1 Sanofi Corporation Information
  • 12.2.2 Sanofi Business Overview
  • 12.2.3 Sanofi Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Sanofi Kidney Disease Drugs Products Offered
  • 12.2.5 Sanofi Recent Development
• 12.3 Roche
  • 12.3.1 Roche Corporation Information
  • 12.3.2 Roche Business Overview
  • 12.3.3 Roche Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Roche Kidney Disease Drugs Products Offered
  • 12.3.5 Roche Recent Development
• 12.4 Pfizer
  • 12.4.1 Pfizer Corporation Information
  • 12.4.2 Pfizer Business Overview
  • 12.4.3 Pfizer Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Pfizer Kidney Disease Drugs Products Offered
  • 12.4.5 Pfizer Recent Development
• 12.5 AstraZeneca
  • 12.5.1 AstraZeneca Corporation Information
  • 12.5.2 AstraZeneca Business Overview
  • 12.5.3 AstraZeneca Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 AstraZeneca Kidney Disease Drugs Products Offered
  • 12.5.5 AstraZeneca Recent Development
• 12.6 Keryx Biopharmaceuticals
  • 12.6.1 Keryx Biopharmaceuticals Corporation Information
  • 12.6.2 Keryx Biopharmaceuticals Business Overview
  • 12.6.3 Keryx Biopharmaceuticals Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Keryx Biopharmaceuticals Kidney Disease Drugs Products Offered
  • 12.6.5 Keryx Biopharmaceuticals Recent Development
• 12.7 Kissei Pharmaceutical
  • 12.7.1 Kissei Pharmaceutical Corporation Information
  • 12.7.2 Kissei Pharmaceutical Business Overview
  • 12.7.3 Kissei Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Kissei Pharmaceutical Kidney Disease Drugs Products Offered
  • 12.7.5 Kissei Pharmaceutical Recent Development
• 12.8 AbbVie
  • 12.8.1 AbbVie Corporation Information
  • 12.8.2 AbbVie Business Overview
  • 12.8.3 AbbVie Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 AbbVie Kidney Disease Drugs Products Offered
  • 12.8.5 AbbVie Recent Development
• 12.9 Amgen
  • 12.9.1 Amgen Corporation Information
  • 12.9.2 Amgen Business Overview
  • 12.9.3 Amgen Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Amgen Kidney Disease Drugs Products Offered
  • 12.9.5 Amgen Recent Development
• 12.10 Teva Pharmaceutical Industries
  • 12.10.1 Teva Pharmaceutical Industries Corporation Information
  • 12.10.2 Teva Pharmaceutical Industries Business Overview
  • 12.10.3 Teva Pharmaceutical Industries Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Teva Pharmaceutical Industries Kidney Disease Drugs Products Offered
  • 12.10.5 Teva Pharmaceutical Industries Recent Development
• 12.11 Tianjin Tongrentang Group
  • 12.11.1 Tianjin Tongrentang Group Corporation Information
  • 12.11.2 Tianjin Tongrentang Group Business Overview
  • 12.11.3 Tianjin Tongrentang Group Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Tianjin Tongrentang Group Kidney Disease Drugs Products Offered
  • 12.11.5 Tianjin Tongrentang Group Recent Development
• 12.12 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
  • 12.12.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Corporation Information
  • 12.12.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Business Overview
  • 12.12.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Products Offered
  • 12.12.5 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Recent Development
• 12.13 Datong Liqun Pharmaceutical
  • 12.13.1 Datong Liqun Pharmaceutical Corporation Information
  • 12.13.2 Datong Liqun Pharmaceutical Business Overview
  • 12.13.3 Datong Liqun Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Datong Liqun Pharmaceutical Kidney Disease Drugs Products Offered
  • 12.13.5 Datong Liqun Pharmaceutical Recent Development
• 12.14 Hebei Ruisen Pharmaceutical
  • 12.14.1 Hebei Ruisen Pharmaceutical Corporation Information
  • 12.14.2 Hebei Ruisen Pharmaceutical Business Overview
  • 12.14.3 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Products Offered
  • 12.14.5 Hebei Ruisen Pharmaceutical Recent Development
• 12.15 Changxing Pharmaceutical
  • 12.15.1 Changxing Pharmaceutical Corporation Information
  • 12.15.2 Changxing Pharmaceutical Business Overview
  • 12.15.3 Changxing Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.15.4 Changxing Pharmaceutical Kidney Disease Drugs Products Offered
  • 12.15.5 Changxing Pharmaceutical Recent Development
• 12.16 zhejiang Shengbokang Pharmaceutical
  • 12.16.1 zhejiang Shengbokang Pharmaceutical Corporation Information
  • 12.16.2 zhejiang Shengbokang Pharmaceutical Business Overview
  • 12.16.3 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.16.4 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Products Offered
  • 12.16.5 zhejiang Shengbokang Pharmaceutical Recent Development

13 Kidney Disease Drugs Manufacturing Cost Analysis

• 13.1 Kidney Disease Drugs Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Kidney Disease Drugs
• 13.4 Kidney Disease Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Kidney Disease Drugs Distributors List
• 14.3 Kidney Disease Drugs Customers

15 Market Dynamics

• 15.1 Kidney Disease Drugs Market Trends
• 15.2 Kidney Disease Drugs Drivers
• 15.3 Kidney Disease Drugs Market Challenges
• 15.4 Kidney Disease Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List